Table 6 Incremental cost-effectiveness ratios for different treatment strategies
Strategy | Cost ($) | Incremental Cost ($) | Effect | Incremental Effect | Incremental cost effectiveness ratio ($) |
|---|---|---|---|---|---|
CAPOX | 2811.11 | 0 | 0.75 | 0 | 0 |
FOLFOX | 2974.14 | 163.02 | 0.75 | 0 | Weakly Dominated |
CAPOX plus Trastuzumab | 6128 | 3316.88 | 0.92 | 0.17 | 19089.94 |
FOLFOX plus Trastuzumab | 8370.67 | 2242.67 | 0.92 | 0 | Weakly Dominated |